Biophytis Reports 2024 Results, Net Loss Widens

Biophytis SA 6-K Filing Summary
FieldDetail
CompanyBiophytis SA
Form Type6-K
Filed DateJun 24, 2025
Risk Levelmedium
Sentimentbearish

Sentiment: bearish

Topics: financial-results, loss, revenue-decline, strategic-review

TL;DR

Biophytis 2024 net loss up to €37.5M, revenue down, strategic review underway.

AI Summary

On June 19, 2025, Biophytis S.A. issued a press release announcing its financial results for the fiscal year ended December 31, 2024. The company reported a net loss of €37.5 million for 2024, compared to a net loss of €34.2 million in 2023. Revenue for 2024 was €0.8 million, a decrease from €1.2 million in 2023. The company also announced a strategic review of its operations and potential financing options.

Why It Matters

The widening net loss and decrease in revenue indicate potential financial challenges for Biophytis, which could impact its ongoing research and development activities.

Risk Assessment

Risk Level: medium — The company reported a widening net loss and decreasing revenue, alongside a strategic review, suggesting potential financial instability.

Key Numbers

  • €37.5M — 2024 Net Loss (Represents a significant increase in losses compared to the previous year.)
  • €0.8M — 2024 Revenue (Indicates a decline in the company's income generation.)

Key Players & Entities

  • Biophytis S.A. (company) — Registrant
  • Stanislas Veillet (person) — Contact Person
  • June 19, 2025 (date) — Press Release Date
  • December 31, 2024 (date) — Fiscal Year End
  • €37.5 million (dollar_amount) — 2024 Net Loss
  • €34.2 million (dollar_amount) — 2023 Net Loss
  • €0.8 million (dollar_amount) — 2024 Revenue
  • €1.2 million (dollar_amount) — 2023 Revenue

FAQ

What was Biophytis S.A.'s net loss for the fiscal year ended December 31, 2024?

Biophytis S.A. reported a net loss of €37.5 million for the fiscal year ended December 31, 2024.

How did Biophytis S.A.'s revenue in 2024 compare to 2023?

Biophytis S.A.'s revenue in 2024 was €0.8 million, a decrease from €1.2 million in 2023.

When was the press release announcing these financial results issued?

The press release was issued on June 19, 2025.

What strategic actions is Biophytis S.A. considering?

Biophytis S.A. announced a strategic review of its operations and potential financing options.

What is the principal executive office address of Biophytis S.A.?

The principal executive office is located at Sorbonne University—BC 9, Bâtiment A 4ème étage 4 place Jussieu 75005 Paris, France.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 24, 2025 by Stanislas Veillet regarding Biophytis SA.

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.